Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells

British Journal of Cancer

Volumn 73, Issue 9, 1996, Pages 1053-1062

  McLeskey, S W ^a,b   Zhang, L ^a,b   Trock, B J ^a,b   Kharbanda, S ^a   Liu, Y ^a   Gottardis, M M ^c   Lippman, M E ^a,b   Kern, F G ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

AGM 1470; Angiogenesis; Breast cancer; FGF; MCF 7 cells; Pentosan polysulphate

Indexed keywords

ANGIOGENESIS INHIBITOR; FIBROBLAST GROWTH FACTOR; FUMAGILLOL CHLOROACETYLCARBAMATE; PENTOSAN POLYSULFATE; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENICITY; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

EID: 0029972404     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.204     Document Type: Article

References (61)

1. ABE J, ZHOU W, TAKUWA N, TAGUCHI J, KUROKAWA K, KUMADA M AND TAKUWA Y. (1994). A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. Cancer Res., 54, 3407-3412.
2. ADNANE J, GAUDRAY P, DIONNE CA, CRUMLEY G, JAYE M, SCHLESSINGER J, JEANTEUR P, BIRNBAUM D AND THEILLET C. (1991). BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene, 6, 659-663.
3. 1 phase of the cell cycle. Cancer Res., 54, 2073-2076.
4. ARTEAGA CL, TANDON AK, VON HOFF DD AND OSBORNE CK. (1988). Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res., 48, 3898-3904.
5. 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differ., 4, 193-201.
6. BARNARD JA, LYONS RM AND MOSES HL. (1990). The cell biology of transforming growth factor β. Biochim. Biophys. Acta, 1032, 79-87.
7. BELFORD DA, HENDRY IA AND PARISH CR. (1993). Investigation of the ability of several naturally occurring and synthetic polyanions to bind to and potentiate the biological activity of acidic fibroblast growth factor. J. Cell Physiol., 157, 184-189.
8. BREM S, TSANACLIS AMC, GATELY S, GROSS JL AND HERBLIN WF. (1992). Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer, 70, 2673-2680.
9. BREM H, GRESSER I, GROSFELD J AND FOLKMAN J. (1993). The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J. Ped. Surg., 28, 1253-1257.
10. BURGESS WH AND MACIAG T. (1989). The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem., 58, 575-606.
11. BURGESS W, MEHLMAN T, MARSHAK D, FRASER B AND MACIAG T. (1986). Structural evidence that endothelial cell growth factor beta is the precursor of both endothelial cell growth factor alpha and acidic fibroblast growth factor. Proc. Natl Acad. Sci. USA, 83, 7216-7220.
12. 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res., 52, 4261-4264.
13. 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am. J. Pathol., 143, 381-389.
14. DING IYF, MCLESKEY SW, CHANG K, FU YM, ACOL JC, SHOU MT, ALITALO K AND KERN FG. (1992). Expression of fibroblast growth factors (FGFs) and receptors (FGFRs) in human breast carcinomas (abstract). Proc. Am. Assoc. Cancer Res., 33, 269.
15. FLAMM SL, WELLSTEIN A, LUPU R, KERN F, LIPPMAN ME AND GELMANN EP. (1989). Expression of fibroblast growth factor peptides in normal and malignant human mammary epithelial cells. Proc. Am. Assoc. Cancer Res., 30, 71.
16. FOLKMAN J AND SHING Y. (1992). Angiogenesis. J. Biol. Chem., 267, 10931-10934.
17. FOLKMAN J, WATSON K, INGBER D AND HANAHAN D. (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature, 339, 58-61.
18. FOROUGH R, ZHAN X, MACPHEE M, FRIEDMAN S, ENGLEKA KA, SAYERS T, WILTROUT RH AND MACIAG T. (1993). Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1. J. Biol. Chem., 268, 2960-2968.
19. GAGLIARDI A AND COLLINS DC. (1993). Inhibition of angiogenesis by antiestrogens. Cancer Res., 53, 533-535.
20. GAGLIARDI A, TAYLOR M, HENNIG, B AND COLLINS DC. (1995). Antiestrogens inhibit endothelial cell growth. Proc. Am. Assoc. Cancer Res., 36, 170.
21. GAJDUSEK CM, LUO Z AND MAYBERG MR. (1993). Basic fibroblast growth factor and transforming growth factor beta-1: synergistic modulators of angiogenesis in vitro. J. Cell Physiol., 157, 133-144.
22. GOMM JJ, SMITH J, RYALL GK, BAILLIE R, TURNBULL L AND COOMBES RC. (1991). Localization of basic fibroblast growth factor and transforming growth factor beta 1 in the human mammary gland. Cancer Res., 51, 4685-4692.
23. HALABAN R. (1993). Growth regulation in normal and malignant melanocytes. Recent Results Cancer Res., 128, 133-150.
24. HARAN EF, MARETZEK AF, GOLDBERG I, HOROWITZ A AND DEGANI H. (1994). Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res., 54, 5511-5514.
25. HEITJAN DF, MANNI A AND SANTEN RJ. (1993). Statistical analysis of in vivo tumor growth experiments. Cancer Res., 53, 6042-6050.
26. INGBER D, FUJITA T, KISHIMOTO S, SUDO K, KANAMARU T, BREM H AND FOLKMAN J. (1990). Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature, 348, 555-557.
27. JAAKKOLA S, SALMIKANGAS P, NYLUND S, PARTANEN J, ARMSTRON E, PYRHÖNEN S, LEHTOVIRTA P AND NEVANLINNA H. (1993). Amplification of fgfr4 gene in human breast and gynecological cancers. Int. J. Cancer, 54, 378-382.
28. KANDEL J, BOSSY-WETZEL E, RADVANYI F, KLAGSBRUN M, FOLKMAN J AND HANAHAN D. (1991). Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell, 66, 1095-1104.
29. KATO T, SATO K, KAKINUMA H AND MATSUDA Y. (1994). Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbarnoyl)fumagillol (TNP-470) and cytotoxic agents in mice. Cancer Res., 54, 5143-5147.
30. KNABBE C, LIPPMAN ME, WAKEFIELD LM, FLANDERS KC, KASID A, DERYNCK R AND DICKSON RB. (1987). Evidence that transforming growth factor beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48, 417-428.
31. KNABBE C, ZUGMAIER G, SCHMAHL M, DIETEL M, LIPPMAN ME AND DICKSON RB. (1991). Induction of transforming growth factor β by the antiestrogens droloxifene, tamoxifen, and toremifene in MCF-7 cells. Am. J. Clin. Oncol. 14, s15-s20.
32. KUREBAYASHI J, MCLESKEY SW, JOHNSON MD, LIPPMAN ME, DICKSON RB AND KERN FG. (1993). Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfectcd with fibroblast growth factor 4 and LacZ. Cancer Res., 53, 2178-2187.
33. KUREBAYASHI J, KUROSUMI M, DICKSON RB AND SONOO H. (1994). Angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470) inhibits tumor angiogenesis, growth and spontaneous metastasis of MKL-4 human breast cancer cells in female athymic nude mice. Breast Cancer, 1, 109-115.
34. KUSAKA M, SUDO K, FUJITA T, MARUI S, ITOH F, INGBER D AND FOLKMAN J. (1991). Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun., 174, 1070-1076.
35. KUSAKA M, SUDO K, MATSUTANI E, KOZAI Y, MARUI S, FUJITA T, INGBER D AND FOLKMAN J. (1994). Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br. J. Cancer, 69, 212-216.
36. LUQMANI YA, MORTIMER C, YIANGOU C, JOHNSTON CL, BANSAL GS, SINNETT D, LAW M AND COOMBES RC. (1995). Expression of two variant forms of fibroblast growth factor receptor type 1 in human breast. Int. J. Cancer, 64, 274-279.
37. MCLESKEY SW, KUREBAYASHI J, HONIG SF, ZWIEBEL J, LIPPMAN ME, DICKSON RB AND KERN FG. (1993). Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res., 53, 2168-2177.
38. MCLESKEY SW, ZHANG L, KHARBANDA S, KUREBAYASHI J, LIPPMAN ME, DICKSON RB AND KERN FG. (1996). Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis. Breast Cancer Res. Treat. (in press).
39. MILLER DL, EL-ASHRY D, CHEVILLE AL, LIU Y, MCLESKEY SW AND KERN FG. (1994). Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Different., 5, 1263-1274.
40. MORI S, UEDA T, KURATSU S, HOSONO N, IZAWA K AND UCHIDA A. (1995). Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma. Int. J. Cancer, 61, 148-152.
41. O'REILLY MS, BREM H AND FOLKMAN J. (1995). Treatment of murine hemangioendotheliomas with the angiogenesis inhibitor AGM-1470. J. Ped. Surg., 30, 325-330.
42. OSBORNE CK, HOBBS K AND CLARK GM. (1985). Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res., 45, 584-590.
43. PANTOLIANO MW, HORLICK RA, SPRINGER BA, VAN DYK DE, TOBERY T, WETMORE DR, LEAR JD, NAHAPETIAN AT, BRADLEY JD AND SISK WP. (1994). Multivalent ligand-receptor binding interactions in the fibroblast growth factor systems produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry, 33, 10229-12048.
44. PENAULT-LLORCA F, BERTUCCI F, ADÉLAIDE J, PARC P, COULIER F, JACQUEMIER J, BIRNBAUM D AND DELAPEYRIERE O. (1995). Expression of FGF and FGF receptor genes in human breast cancer. Int. J. Cancer, 61, 170-176.
45. PLACIDI L, CRETTON-SCOTT E, DE SOUSA G,RAHMANI R, PLACIDI M AND SOMMADOSSI J-P. (1995). Disposition and metabolism of the angiogenic moderator O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) in human hepatocytes and tissue microsomes. Cancer Res., 55, 3036-3042.
46. RAYCHAUDHURY A AND D'AMORE PA. (1993). Endothelial cell regulation by transforming growth factor-beta. J. Cell Biochem., 47, 224-229.
47. ROBERTS AB, WAKEFIELD LM, LETTERIO JJ, GEISER AG, KIM S-J, DANIELPOUR D, ANZANO MA, LUCIA S AND SPORN MB. (1995). TGF-β: Complex role in carcinogenesis. Proc. Am. Assoc. Cancer Res., 36, 651.
48. SMITH J, YELLAND A, BAILLIE R AND COOMBES RC. (1994). Acidic and basic fibroblast growth factors in human breast tissue. Eur. J. Cancer, 30A, 496-503.
49. SOULE HD AND MCGRATH CM. (1980). Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett., 10, 1140-1151.
50. SUN L, WU G. WILLSON JKV, ZBOROWSKA E, YANG J, RAJKAR-UNANAYAKE I, WANG J, GENTRY LE, WANG X-F AND BRATTAIN MG. (1994). Expression of transforming growth factor β type II receptor loads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem., 269, 26449-26455.
51. 1 in ductal carcinoma in situ and invasive carcinomas of the breast. Eur. J. Cancer, 28, 641-644.
52. WEINSTAT-SASLOW D AND STEEG PS. (1994). Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J., 8, 401-407.
53. WELCH DR, FABRA A AND NAKAJIMA M. (1990). Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl Acad. Sci. USA, 87, 7678-7682.
54. WELLSTEIN A, ZUGMAIER G, CALIFANO JA, 3D, KERN F, PAIK S AND LIPPMAN ME. (1991). Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J. Natl Cancer Inst., 83, 716-720.
55. YAMAGUCHI F, SAYA H, BRUNER JM AND MORRISON RS. (1994). Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc. Natl Acad. Sci. USA, 91, 484-488.
56. YAMAMOTO T, SUDO K AND FUJITA T. (1994). Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res., 14, 1-4.
57. YAMAOKA M, YAMAMOTO T, MASAKI T, IKEYAMA S, SUDO K AND FUJITA T. (1993). Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res., 53, 4262-4267.
58. YAN G, FUKABORI Y, MCBRIDE G, NIKOLAROPOLOUS S AND MCKEEHAN WL. (1993). Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell Biol., 13, 4513-4522.
59. YANASE T, TAMURA M, FUJITA K, KODAMA S AND TANAKA K. (1993). Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis on human cell lines in vitro and in riro. Cancer Res., 53, 2566-2570.
60. ZHANG L, KHARBANDA S, CHEN D, MILLER DL, DING IYF, HANFELT J, MCLESKEY SW AND KERN EG (1996). MCF-7 breast carcinoma cells overexpressing FGF-1 form vuscularized, metastatic tumours in ovariectomized or tamoxifen-treated nude mice. Cancer Res. (submitted).
61. ZUGMAIER G, LIPPMAN ME AND WELLSTEIN A. (1992). Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals. J. Natl Cancer Inst., 84, 1716-1724.